IBSA Pharma Inc.
Pharmaceutical & medical device company payment data from CMS Open Payments.
Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $956,604 | 50,512 | 62.7% |
| Consulting Fee | $285,525 | 365 | 18.7% |
| Unspecified | $202,991 | 18 | 13.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $36,970 | 66 | 2.4% |
| Honoraria | $28,551 | 15 | 1.9% |
| Travel and Lodging | $16,238 | 51 | 1.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| Comparison of Levothyroxine Formulation in Hypothyroid Patients with Enteral Feeding | $73,881 | 0 | 2 |
| Liquid Thyroxine Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth Syndrome (SIBO) | $58,940 | 0 | 4 |
| Efficacy and Safety of LICART ( diclofenac epolamine), DHEP) Topical System in the Emergency Department: A prospective Observational Study | $31,175 | 0 | 2 |
| Liquid Thyroxine Improved Outcomes in Hypothyroid Patients with Small Intestinal Bacterial Overgrowth Syndrome (SIBO) | $13,928 | 0 | 4 |
| Efficacy and Safety of Licart (Diclofenac Epolamine, DHEP) Topical System 1.3% in Patients with Acute Back Pain: A Prospective Observational Study | $9,853 | 0 | 4 |
| Use of Liquid Stable Levothyroxine in Trisomy 21 Pediatric Patients | $9,100 | 0 | 1 |
| Efficacy and Safety of LICART (diclofenac epolamine, DHEP) Topical System in the Emergency Department: A Prospective Observational Study | $6,115 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Ernest Asamoah, Md, MD | Endocrinology, Diabetes & Metabolism | Indianapolis, IN | $17,110 | $0 |
| Mr. Bruce Trippe, M.d, M.D | Endocrinology, Diabetes & Metabolism | Dothan, AL | $16,273 | $0 |
| Todd Stitik, M.d, M.D | Pain Medicine | Newark, NJ | $15,234 | $0 |
| Dr. Eric Langer, Do, DO | Endocrinology, Diabetes & Metabolism | Sterling Heights, MI | $12,595 | $0 |
| Felice Gersh, Md, MD | Gynecology | Irvine, CA | $12,505 | $0 |
| Leonard Wartofsky, Md, MD | Endocrinology, Diabetes & Metabolism | Washington, DC | $12,053 | $0 |
| Dr. Mae Sheikh-Ali, M.d, M.D | Endocrinology, Diabetes & Metabolism | Jacksonville, FL | $10,537 | $0 |
| Dr. Gerald Sacks, M.d, M.D | Pain Medicine | Santa Monica, CA | $10,276 | $0 |
| Philip Doh, Md, MD | Pain Medicine | Los Angeles, CA | $10,242 | $0 |
| Dr. Sandra Kwak, M.d, M.D | Endocrinology, Diabetes & Metabolism | Newport Beach, CA | $9,747 | $0 |
| Dr. Brittany Henderson, Md, MD | Endocrinology, Diabetes & Metabolism | Mount Pleasant, SC | $9,464 | $0 |
| Dr. Ammar Qoubaitary, M.d, M.D | Endocrinology, Diabetes & Metabolism | San Ramon, CA | $8,821 | $0 |
| Lee Metchick, Md, MD | Endocrinology, Diabetes & Metabolism | Deland, FL | $8,593 | $0 |
| Dr. Osric King, Md, MD | Specialist | Fresh Meadows, NY | $8,470 | $0 |
| Dr. Andrew Adler, Dpm, DPM | Foot & Ankle Surgery | Matthews, NC | $8,403 | $0 |
| Kenilia Ventura, M.d, M.D | Hospitalist | Jupiter, FL | $8,000 | $0 |
| Dr. Francesco Celi, M.d, M.D | Endocrinology, Diabetes & Metabolism | Farmington, CT | $6,339 | $0 |
| Wai Bong, Pa, PA | Medical | Flushing, NY | $5,925 | $0 |
| Dr. Joselito Cabaccan, Md, MD | Endocrinology, Diabetes & Metabolism | San Jose, CA | $5,529 | $0 |
| Dr. Madelin Ramil, Dpm, DPM | Foot & Ankle Surgery | Plantation, FL | $5,399 | $0 |
| Elizabeth Board, Md, MD | General Practice | Alpharetta, GA | $5,360 | $0 |
| Unknown Provider | — | — | $4,873 | $0 |
| Zehra Hyderi, Dpm, DPM | Primary Podiatric Medicine | Algonquin, IL | $4,713 | $0 |
| Hong Chen | Physician Assistant | Brooklyn, NY | $4,684 | $0 |
| Dr. Lara Paraskos, Md, MD | Endocrinology, Diabetes & Metabolism | South Miami, FL | $4,419 | $0 |
About IBSA Pharma Inc.
IBSA Pharma Inc. has made $1.5M in payments to 17,143 healthcare providers, recorded across 51,027 transactions in the CMS Open Payments database. In 2024, the company paid $263,411. The top product by payment volume is Tirosint ($1.1M).
Payments were distributed across 190 medical specialties. The top specialty by payment amount is Endocrinology, Diabetes & Metabolism ($353,787 to 1,568 doctors).
Payment categories include: Food & Beverage ($956,604), Consulting ($285,525), Research ($202,991), Travel & Lodging ($16,238).
IBSA Pharma Inc. is associated with 2 products in the CMS Open Payments database.